Our experience with octoclothepine therapy.
D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003988:Dibenzothiepins / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D003988:Dibenzothiepins; D010879:Piperazines; D014149:Tranquilizing Agents